Fineline Cube

Follow:
14436 Articles
BioTroy Therapeutics Secures USD 28M in Series A Funding for CD3L1 Anti-Tumor Drug Development
CompanyDeals

BioTroy Therapeutics Secures USD 28M in Series A Funding for CD3L1 Anti-Tumor Drug Development

GlycoT Therapeutics Partners with Innovent Biologics to Advance ADC Technology
CompanyDeals

GlycoT Therapeutics Partners with Innovent Biologics to Advance ADC Technology

Shanghai Escugen and SunRock Biopharma Collaborate on First-in-Class CCR9-Targeted ADC
CompanyDeals

Shanghai Escugen and SunRock Biopharma Collaborate on First-in-Class CCR9-Targeted ADC

AbbVie's Venclexta Fails to Meet Overall Survival Endpoint in HR-MDS Trial
CompanyDrug

AbbVie’s Venclexta Fails to Meet Overall Survival Endpoint in HR-MDS Trial

Harbour BioMed Wins CNIPA Validation of 'Binding Molecule' Patent Amid Dispute
CompanyLegal / IP

Harbour BioMed Wins CNIPA Validation of ‘Binding Molecule’ Patent Amid Dispute

Roche Advances Prasinezumab to Phase III for Early Parkinson's Disease
CompanyDrug

Roche Advances Prasinezumab to Phase III for Early Parkinson’s Disease

Simcere and NextCure Forge Strategic Alliance to Co-Develop SIM0505 ADC for Solid Tumors
CompanyDeals

Simcere and NextCure Forge Strategic Alliance to Co-Develop SIM0505 ADC for Solid Tumors

AstraZeneca's Oncology Executive Mike La to Leave Company in June
Company

AstraZeneca’s Oncology Executive Michael Lai to Leave Company in June

Eli Lilly Close to Acquiring Verve Therapeutics for Up to USD 1.3 Billion
CompanyDeals

Eli Lilly Close to Acquiring Verve Therapeutics for Up to USD 1.3 Billion

Pediatrix Therapeutics Wins Macau Approval for Neffy Epinephrine Nasal Spray
CompanyDrug

Pediatrix Therapeutics Wins Macau Approval for Neffy Epinephrine Nasal Spray

Minova Pharmaceuticals Launches Rongzhi, China's First Injectable Adipocytolytic Drug
CompanyDrug

Minova Pharmaceuticals Launches Rongzhi, China’s First Injectable Adipocytolytic Drug

RemeGen Secures 1,827-Day Patent Extension for Telitacicept in China
Legal / IP

RemeGen Secures 1,827-Day Patent Extension for Telitacicept in China